Concepedia
Statistics
Publications
4
Citations
124
H-Index
Active since
2020
Affiliations
Hanmi Pharmaceutical (South Korea)(Current)
Ajou University
Kyung Hee University
Sungkyunkwan University
Samsung Medical Center
Hyewon Nam is an author at Hanmi Pharmaceutical (South Korea) specializing in diabetes, clinical trials, and cardiovascular disease.
Top concepts
Covid-19DiabetesMedicineEpidemiologyHealth PolicyPublic HealthClinical TrialsPharmacotherapyClinical OutcomesClinical Epidemiology
Publications per year
2020–2024
Effects of a DPP-4 Inhibitor and RAS Blockade on Clinical Outcomes of Patients with Diabetes and COVID-19
Sang Youl Rhee, Jeong-Woo Lee, Hyewon Nam et al. · Diabetes & Metabolism Journal · 2021 · 54 citations · Full text
Effects of a DPP-4 inhibitor and RAS blockade on clinical outcomes of patients with diabetes and COVID-19
Sang Youl Rhee, Jeongwoo Lee, Hyewon Nam et al. · 2020 · 33 citations · Full text
Disease Management, Pharmacotherapy, Covid-19 Epidemiology +21
Fenofibrate Use Is Associated With Lower Mortality and Fewer Cardiovascular Events in Patients With Diabetes: Results of 10,114 Patients From the Korean National Health Insurance Service Cohort
Sang‐Ho Jo, Hyewon Nam, Jeongwoo Lee et al. · Diabetes Care · 2021 · 26 citations · Full text
Total knee arthroplasty and periprosthetic distal femoral fracture: looking beyond the osteoporosis to previous osteoporotic fracture
Yong‐Beom Park, Matthew Kim, Hyewon Nam et al. · Osteoporosis International · 2024 · 11 citations
1–4 of 4